ADORA2A and schizophrenia: In this respect, it is particularly worth noting again that contrary to the central tenet of the adenosine hypothesis, animal models continue to suggest that inhibition of striatal ADORA2A activity may potentially alleviate not only negative symptoms, but also cognitive impairments, related to schizophrenia.